Financials
Financial year 2025
APOTHEEK VANDENBOSCH C. from Leuven, company number BE0866987285, closed financial year 2025 with a result of € 71,502 after tax. For that financial year APOTHEEK VANDENBOSCH C. recorded a gross margin of € 205,235 and equity of € 419,940. Compared with financial year 2024, the result moved from € 27,978 to € 71,502. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.
€ 419,940
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 71,502
▲ 156% vs 2024
Profit after tax over the fiscal year.
€ 207,377
▲ 52% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 18,699 paid out
26 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 78,056
▲ 3% vs 2024
€ 78,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 810
▼ 50% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 43,815
▲ 13% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 20,633
▼ 14% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 183,728 | € 154,561 | € 146,644 | € 205,235 | ▲ 40% |
| Profit after taxes | € 64,228 | € 27,410 | € 27,978 | € 71,502 | ▲ 156% |
| Equity | € 356,129 | € 344,474 | € 367,137 | € 419,940 | ▲ 14% |
| Total debts | € 137,991 | € 118,279 | € 76,286 | € 91,877 | ▲ 20% |
| Cash | € 101,472 | € 115,395 | € 136,119 | € 207,377 | ▲ 52% |
| Land & buildings | € 229,507 | € 206,499 | € 183,491 | € 160,483 | ▼ 13% |
| Retained profit | € 337,529 | € 325,874 | € 348,537 | € 401,340 | ▲ 15% |
| Dividend | € 19,591 | € 39,065 | € 5,315 | € 18,699 | ▲ 252% |
| Bank debt | € 43,022 | € 8,405 | € 0 | € 0 | |
| Balance sheet total | € 494,120 | € 462,753 | € 443,423 | € 511,818 | ▲ 15% |
| Employees (FTE) | 1.1 | 1 | 1 | 1 |
Key figures of APOTHEEK VANDENBOSCH C., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK VANDENBOSCH C.?
What happened at APOTHEEK VANDENBOSCH C. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 71,502 (▲ 156% vs 2024). Source: NBB ↗
- New establishment in Leuven. KBO
- Catherine Vandenbosch became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 64,228 profit in 2022 to € 71,502 profit in 2025.
Paid € 75,611 in corporate taxes since 2022.
Best year ever: 2025, with € 71,502 profit.
On average € 205,200 of value added per employee in 2025.
A new publication or filing at APOTHEEK VANDENBOSCH C.? We notify you, reason included.
Follow APOTHEEK VANDENBOSCH C.Databakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind APOTHEEK VANDENBOSCH C. is Catherine Vandenbosch. The shares are held by Catherine Vandenbosch (100%).
Directors
According to the 2025 annual accounts
Catherine Vandenbosch
Director
Owns 100% directly
since 2004
Shareholders
Catherine Vandenbosch · director
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Brusselsestraat 136
3000 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0866.987.285
- VAT number
- BE 0866.987.285
- Registered office
- Brusselsestraat 136, 3000 Leuven
- Names & denominations
- APOTHEEK VANDENBOSCH C.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 August 2004
- Peppol
- Active · Active since 16 Dec 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels